These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18005454)

  • 1. Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning.
    Abe K; Kobayashi N; Sode K; Ikebukuro K
    BMC Bioinformatics; 2007 Nov; 8():451. PubMed ID: 18005454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence determinants regulating fibrillation of human alpha-synuclein.
    Koo HJ; Lee HJ; Im H
    Biochem Biophys Res Commun; 2008 Apr; 368(3):772-8. PubMed ID: 18261982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effects of biomimetically designed peptides on α-synuclein aggregation.
    Rezaeian N; Shirvanizadeh N; Mohammadi S; Nikkhah M; Arab SS
    Arch Biochem Biophys; 2017 Nov; 634():96-106. PubMed ID: 28965745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico panning for a non-competitive peptide inhibitor.
    Yagi Y; Terada K; Noma T; Ikebukuro K; Sode K
    BMC Bioinformatics; 2007 Jan; 8():11. PubMed ID: 17222344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular simulation of protein aggregation.
    Bratko D; Cellmer T; Prausnitz JM; Blanch HW
    Biotechnol Bioeng; 2007 Jan; 96(1):1-8. PubMed ID: 17136749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
    Jha NN; Ranganathan S; Kumar R; Mehra S; Panigrahi R; Navalkar A; Ghosh D; Kumar A; Padinhateeri R; Maji SK
    Biochemistry; 2018 Feb; 57(5):791-804. PubMed ID: 29286644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single particle detection and characterization of synuclein co-aggregation.
    Giese A; Bader B; Bieschke J; Schaffar G; Odoy S; Kahle PJ; Haass C; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1202-10. PubMed ID: 15978545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following the aggregation of amyloid-forming peptides by computer simulations.
    Melquiond A; Boucher G; Mousseau N; Derreumaux P
    J Chem Phys; 2005 May; 122(17):174904. PubMed ID: 15910066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.
    Fernandez-Escamilla AM; Rousseau F; Schymkowitz J; Serrano L
    Nat Biotechnol; 2004 Oct; 22(10):1302-6. PubMed ID: 15361882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.
    Liang Z; Chan HYE; Lee MM; Chan MK
    Cell Chem Biol; 2021 Feb; 28(2):180-190.e6. PubMed ID: 33444530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
    FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replica exchange molecular dynamics simulations of amyloid peptide aggregation.
    Cecchini M; Rao F; Seeber M; Caflisch A
    J Chem Phys; 2004 Dec; 121(21):10748-56. PubMed ID: 15549960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein aggregation in silico.
    Cellmer T; Bratko D; Prausnitz JM; Blanch HW
    Trends Biotechnol; 2007 Jun; 25(6):254-61. PubMed ID: 17433843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modeling of protein interactions by analogy: application to PSD-95.
    Korkin D; Davis FP; Alber F; Luong T; Shen MY; Lucic V; Kennedy MB; Sali A
    PLoS Comput Biol; 2006 Nov; 2(11):e153. PubMed ID: 17096593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of model systems for amyloid formation: lessons for prediction and inhibition.
    Pastor MT; Esteras-Chopo A; López de la Paz M
    Curr Opin Struct Biol; 2005 Feb; 15(1):57-63. PubMed ID: 15718134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the mechanism of peptide aggregation: insights from mixed monte carlo-molecular dynamics simulations.
    Meli M; Morra G; Colombo G
    Biophys J; 2008 Jun; 94(11):4414-26. PubMed ID: 18263661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity.
    Lynch SM; Zhou C; Messer A
    J Mol Biol; 2008 Mar; 377(1):136-47. PubMed ID: 18237741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disordered flanks prevent peptide aggregation.
    Abeln S; Frenkel D
    PLoS Comput Biol; 2008 Dec; 4(12):e1000241. PubMed ID: 19096500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion mobility-mass spectrometry-based screening for inhibition of α- synuclein aggregation.
    Liu Y; Graetz M; Ho L; Pukala TL
    Eur J Mass Spectrom (Chichester); 2015; 21(3):255-64. PubMed ID: 26307705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces.
    Favrin G; Irbäck A; Mohanty S
    Biophys J; 2004 Dec; 87(6):3657-64. PubMed ID: 15377534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.